First Business Financial Services Inc. Invests $240,000 in HCA Healthcare, Inc. (NYSE:HCA)

First Business Financial Services Inc. acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 3rd quarter, Holdings Channel.com reports. The fund acquired 591 shares of the company’s stock, valued at approximately $240,000.

Other large investors also recently made changes to their positions in the company. CIBC Asset Management Inc boosted its holdings in HCA Healthcare by 4.9% during the third quarter. CIBC Asset Management Inc now owns 29,427 shares of the company’s stock worth $11,960,000 after purchasing an additional 1,362 shares during the last quarter. ING Groep NV boosted its holdings in HCA Healthcare by 267.3% during the third quarter. ING Groep NV now owns 49,201 shares of the company’s stock worth $19,997,000 after purchasing an additional 35,807 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. boosted its holdings in HCA Healthcare by 5.6% during the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 5,429 shares of the company’s stock worth $2,207,000 after purchasing an additional 290 shares during the last quarter. Plato Investment Management Ltd lifted its stake in HCA Healthcare by 51.6% in the third quarter. Plato Investment Management Ltd now owns 4,770 shares of the company’s stock valued at $1,937,000 after acquiring an additional 1,624 shares during the last quarter. Finally, OVERSEA CHINESE BANKING Corp Ltd lifted its stake in HCA Healthcare by 23.2% in the third quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 2,923 shares of the company’s stock valued at $1,188,000 after acquiring an additional 550 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling

In related news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. This represents a 21.97 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 15,155 shares of company stock valued at $5,608,990. 1.60% of the stock is owned by insiders.

Analysts Set New Price Targets

HCA has been the subject of a number of recent analyst reports. Barclays cut their price target on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a research note on Friday, November 8th. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. StockNews.com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Wells Fargo & Company increased their price objective on shares of HCA Healthcare from $395.00 to $400.00 and gave the company an “equal weight” rating in a research report on Wednesday, November 6th. Finally, Morgan Stanley initiated coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price target on the stock. Five investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $385.00.

HCA Healthcare Stock Down 1.1 %

NYSE:HCA opened at $345.36 on Friday. The firm’s 50 day simple moving average is $387.05 and its 200 day simple moving average is $357.11. The company has a market cap of $87.48 billion, a PE ratio of 15.51, a P/E/G ratio of 1.34 and a beta of 1.68. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. HCA Healthcare, Inc. has a one year low of $237.57 and a one year high of $417.14.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.76%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio is 11.85%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.